Yuyu Pharma, Inc.

000220 KRX Pharmaceuticals Pharmaceuticals
KOSPI
₩3,855.00
+0.00%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of 0.47.
  • Net profit margin is 6.5%.
  • Current assets comfortably cover current liabilities (current ratio 1.64).
  • Pays a dividend (yield about 2.5%).
  • Has paid a dividend in each of the last 4 years on record.

!Watch-points

  • Return on equity is on the lower side at 6.3%.
  • Return on capital employed is on the lower side at 7.4%.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreDistress zone
1.29

In Altman’s study, scores in this range were associated with a higher incidence of financial distress.

Computed without the market-value term.

Piotroski F-ScoreWeak
3 / 4

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 4 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₩607억
Current Price₩ 3,855.00
High / Low₩ 5,100.00 / 0.00
Stock P/E7.84
Book Value₩ 8,231.89
Dividend Yield2.50%
ROCE7.43%
ROE6.29%
Debt to Equity0.47
Current Ratio1.64
EPS₩ 492.00
PAT Margin6.47%
Compounded Sales Growth
10 Years
5 Years 7.58%
3 Years
TTM
Compounded Profit Growth
10 Years
5 Years 8.58%
3 Years
TTM
Stock Price CAGR
10 Years
5 Years
3 Years
1 Year
Return on Equity
10 Years
5 Years
3 Years
Last Year 6.29%
Educational data only. Not a recommendation to buy, sell or hold any security.